Literature DB >> 28658013

Hippocampal Gray Volumes Increase in Treatment-Resistant Depression Responding to Vagus Nerve Stimulation.

Giulia Ida Perini1, Tommaso Toffanin, Giorgio Pigato, Giovanni Ferri, Halima Follador, Filippo Zonta, Carlo Pastorelli, Giulia Piazzon, Luca Denaro, Giuseppe Rolma, Mario Ermani, Domenico DʼAvella.   

Abstract

BACKGROUND: Changes in hippocampal gray matter volumes are proposed to be involved in pathogenesis, course, and treatment response of major depressive disorder. Converging evidence suggests that reduced neurogenesis may occur in treatment-resistant depression (TRD). Vagus nerve stimulation (VNS) is a well-defined, long-term brain stimulation treatment for TRD. However, its in vivo positive effect on hippocampal modulation as mechanism of action has never been investigated before in clinical studies. In this study, we intended to explore hippocampal volumetric changes and clinical antidepressant responses in patients with TRD after 6 and 12 months of treatment with VNS.
METHODS: The TRD outpatients were evaluated for VNS implantation. Right and left hippocampal volumes in 6 TRD patients, who met the criteria for VNS treatment, were measured at baseline before the implantation and after 6 and 12 months. The patients were assessed using Beck Depression Inventory and Hamilton Depression Rating Scale at baseline and at follow-up visits.
RESULTS: There was a statistically significant and progressive increase in right and left hippocampal volumes during the follow up (P < 0.05). Furthermore, patients showed a significant improvement on Hamilton Depression Rating Scale and Beck Depression Inventory scores (P < 0.05).
CONCLUSIONS: Our data suggest a VNS modulatory effect on hippocampal plasticity as measured by hippocampal gray volume increase in TRD patients. These preliminary findings indicate the fundamental role of hippocampal remodeling as a marker of response to VNS in TRD.

Entities:  

Mesh:

Year:  2017        PMID: 28658013     DOI: 10.1097/YCT.0000000000000424

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  12 in total

1.  The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.

Authors:  Mark J Niciu; Nicolas D Iadarola; Dipavo Banerjee; David A Luckenbaugh; Minkyung Park; Marc Lener; Lawrence Park; Dawn F Ionescu; Elizabeth D Ballard; Nancy E Brutsche; Nirmala Akula; Francis J McMahon; Rodrigo Machado-Vieira; Allison C Nugent; Carlos A Zarate
Journal:  J Psychopharmacol       Date:  2017-10-17       Impact factor: 4.153

Review 2.  A Comprehensive Review of Vagus Nerve Stimulation for Depression.

Authors:  Christopher W Austelle; Georgia H O'Leary; Sean Thompson; Elise Gruber; Alex Kahn; Andrew J Manett; Baron Short; Bashar W Badran
Journal:  Neuromodulation       Date:  2021-09-06

Review 3.  "The Wandering Nerve Linking Heart and Mind" - The Complementary Role of Transcutaneous Vagus Nerve Stimulation in Modulating Neuro-Cardiovascular and Cognitive Performance.

Authors:  Helena Dolphin; Tim Dukelow; Ciaran Finucane; Sean Commins; Paul McElwaine; Sean P Kennelly
Journal:  Front Neurosci       Date:  2022-06-16       Impact factor: 5.152

Review 4.  A narrative review on invasive brain stimulation for treatment-resistant depression.

Authors:  Manoj P Dandekar; Alexandre P Diaz; Ziaur Rahman; Ritele H Silva; Ziad Nahas; Scott Aaronson; Sudhakar Selvaraj; Albert J Fenoy; Marsal Sanches; Jair C Soares; Patricio Riva-Posse; Joao Quevedo
Journal:  Braz J Psychiatry       Date:  2022 May-Jun

Review 5.  A Comprehensive Review of Vagus Nerve Stimulation for Depression.

Authors:  Christopher W Austelle; Georgia H O'Leary; Sean Thompson; Elise Gruber; Alex Kahn; Andrew J Manett; Baron Short; Bashar W Badran
Journal:  Neuromodulation       Date:  2021-09-06

6.  Gray Matter Atrophy: The Impacts of Resective Surgery and Vagus Nerve Stimulation in Drug-Resistant Epilepsy.

Authors:  Jordan Lam; Ryan P Cabeen; Runi Tanna; Lauren Navarro; Christianne N Heck; Charles Y Liu; Brian Lee; Jonathan R Russin; Arthur W Toga; Darrin J Lee
Journal:  World Neurosurg       Date:  2021-02-04       Impact factor: 2.104

7.  Vagus Nerve Stimulation Ameliorates Cognitive Impairment and Increased Hippocampal Astrocytes in a Mouse Model of Gulf War Illness.

Authors:  Lavanya Venkatasamy; Damir Nizamutdinov; Jaclyn Jenkins; Lee A Shapiro
Journal:  Neurosci Insights       Date:  2021-05-28

8.  Structural Plasticity Induced by Ketamine in Human Dopaminergic Neurons as Mechanism Relevant for Treatment-Resistant Depression.

Authors:  Ginetta Collo; Laura Cavalleri; Emilio Merlo Pich
Journal:  Chronic Stress (Thousand Oaks)       Date:  2019-04-10

9.  Quantifying acute physiological biomarkers of transcutaneous cervical vagal nerve stimulation in the context of psychological stress.

Authors:  Nil Z Gurel; Minxuan Huang; Matthew T Wittbrodt; Hewon Jung; Stacy L Ladd; Md Mobashir H Shandhi; Yi-An Ko; Lucy Shallenberger; Jonathon A Nye; Bradley Pearce; Viola Vaccarino; Amit J Shah; J Douglas Bremner; Omer T Inan
Journal:  Brain Stimul       Date:  2019-08-06       Impact factor: 8.955

Review 10.  A Review of Parameter Settings for Invasive and Non-invasive Vagus Nerve Stimulation (VNS) Applied in Neurological and Psychiatric Disorders.

Authors:  Sean L Thompson; Georgia H O'Leary; Christopher W Austelle; Elise Gruber; Alex T Kahn; Andrew J Manett; Baron Short; Bashar W Badran
Journal:  Front Neurosci       Date:  2021-07-13       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.